Isabel Fox

Isabel Fox is one of just a handful of female General Partners in the UK focussed on Life Sciences and Healthcare. She has raised and manages Luminous Ventures, a venture fund investing at the intersection of deep technology and human health. At Luminous Ventures, Isabel has the opportunity to indulge her passion for innovation, investing in visionary founders with breakthrough technologies and backing deep-tech and science that matters. The portfolio includes: Synthace, Hadean, Optellum, Ellipsis, Vital Health, Huma, Mahana Therapeutics, Phenomic AI, Biomage, OxfordVR and many more. Before venture capital, Isabel founded two corporate PR firms focused on the venture ecosystem (two exits), co-founded two software start-ups (one exit) and been an active angel investor in the UK and US. In 2020, Isabel was appointed by UK Research and Innovation to be a member of the main council of Innovate UK, the innovation agency of the United Kingdom.